RecruitingNot Applicable

Bronchial Blockers vs Double-Lumen Tubes in Obese Patients

Spain46 participantsStarted 2024-08-15

Plain-language summary

The goal of this clinical trial is to evaluate the efficacy of bronchial blockers and double-lumen tubes in achieving one-lung ventilation in obese patients undergoing lung resections. The primary question it aims to answer is: • Is intraoperative hypoxia significantly different depending on the device used? Researchers will compare the use of bronchial blockers and double-lumen tubes to assess differences in efficacy and safety. Participants will not be required to perform any tasks.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * BMI ≥ 30 kg/m2 * Diagnostic or clinical suspicion of lung cancer * Lung resection surgery (lobectomy, segmentectomy or wedge resection) by VATS or thoracotomy, requiring one-lung ventilation. * Use of bronchial blocker or double-lumen tube for one-lung ventilation. Exclusion Criteria: * Patients with evident anatomic alterations, in which double-lumen tubes may be contraindicated. * Emergency surgeries.

What they're measuring

Hypoxia

Timeframe: Intraoperative (both from anesthetic induction to one-lung ventilation, and during one-lung ventilation)

Trial details

NCT IDNCT07031986

SponsorPaulo Andrés Cano Jiménez

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-04

Contact for this trial

Paulo Andrés Cano, MD

34 663693744 pauloandresc@gmail.com

View on ClinicalTrials.gov More One-lung Ventilation trials